European Genetics and Anthropology has a neat little tutorial that may be of interest for genetic hobbyists: it provides instructions on how to run the program STRUCTURE on your own genetic data generated by a personal genomics company such as 23andMe or deCODEme.
STRUCTURE is an extremely popular tool among researchers working in population genetics, which allows you to generate plots showing estimates of the proportion of an individual's genome belonging to different population clusters.
The tutorial on the blog shows you how to run your analysis using a subset of just 125 markers selected from your genetic data. That's enough to get a sense of what's going on, but of course having access to more than 500,000 markers from a genome scan theoretically allows you to perform a more powerful analysis using a much larger set of markers (and comparing to, say, the freely available SNP data from the Human Genome Diversity Panel).
It's great to see tools developed by academia being democratised by personal genomics hobbyists. One major benefit: if your personal genomics company does go bankrupt, so long as you've downloaded your data you can still analyse your genetic ancestry...
- Log in to post comments
More like this
Nearly five months after 23andMe dropped the price of its genome scan service from $1000 to $400, personal genomics competitor Navigenics has made its own foray into the lower-cost genetic testing market.
Navigenics has always been the most expensive of the three mainstream genome-scan companies,…
Added in edit: for superb analysis of the announcement from multiple angles, you should also check out Dan Vorhaus' three incisive articles on Genomics Law Report.
Personal genomics company 23andMe announced yesterday on its blog (and in an email to customers) of impending changes to its product…
Late last week I noted an intriguing offer by personal genomics company deCODEme: customers of rival genome scan provider 23andMe can now upload and analyse their 23andMe data through the deCODEme pipeline.
On the face of it that's a fairly surprising offer. As I noted in my previous post,…
Yesterday I discussed the decision of personal genomics company 23andMe to slash its price for a genome scan by 60%, to under $400.
In the comments to that post, industry observer David Hamilton pointed me to an article he's written for BNET on the implications of 23andMe's price plunge, which (…